000306699 001__ 306699
000306699 005__ 20251205120002.0
000306699 037__ $$aDKFZ-2025-02689
000306699 1001_ $$0P:(DE-He78)bb01d83eec5ee7af4d816d0e9fd547a4$$avon Soosten, Laura$$b0$$gfemale$$udkfz
000306699 245__ $$aEstablishing experimental therapeutic modalities and CRISPR/Cas9 screening platforms to interrogate vulnerabilities in pediatric high-grade glioma (pHGG)
000306699 260__ $$c2025
000306699 3367_ $$2DataCite$$aOutput Types/Dissertation
000306699 3367_ $$2ORCID$$aDISSERTATION
000306699 3367_ $$2BibTeX$$aPHDTHESIS
000306699 3367_ $$02$$2EndNote$$aThesis
000306699 3367_ $$0PUB:(DE-HGF)11$$2PUB:(DE-HGF)$$aDissertation / PhD Thesis$$bphd$$mphd$$s1764852127_1585925
000306699 3367_ $$2DRIVER$$adoctoralThesis
000306699 502__ $$aDissertation, Ruprecht-Karls-University Heidelberg, 2025$$bDissertation$$cRuprecht-Karls-University Heidelberg$$d2025$$gCombined Faculty of Mathematics, Engineering and Natural Sciences
000306699 536__ $$0G:(DE-HGF)POF4-312$$a312 - Funktionelle und strukturelle Genomforschung (POF4-312)$$cPOF4-312$$fPOF IV$$x0
000306699 909CO $$ooai:inrepo02.dkfz.de:306699$$pVDB
000306699 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)bb01d83eec5ee7af4d816d0e9fd547a4$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000306699 9131_ $$0G:(DE-HGF)POF4-312$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunktionelle und strukturelle Genomforschung$$x0
000306699 9141_ $$y2025
000306699 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x0
000306699 9201_ $$0I:(DE-He78)B360-20160331$$kB360$$lPädiatrische Gliomforschung$$x1
000306699 980__ $$aphd
000306699 980__ $$aVDB
000306699 980__ $$aI:(DE-He78)B062-20160331
000306699 980__ $$aI:(DE-He78)B360-20160331
000306699 980__ $$aUNRESTRICTED